Drug discovery collaboration will leverage the botanical drug development expertise of both companies
VANCOUVER, BC, June 9, 2022 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) and Jaguar Health, Inc. (NASDAQ: JAGX) today announced that the companies have signed a letter of intent to enter a collaboration agreement to develop botanical prescription drugs for specific psychoactive target indications in the United States. The goal of the collaboration is to extend the botanical drug development skillsets of both companies in order to develop pharmaceutical-grade, standardized drug candidates and partner with a potential future licensee regarding the development and commercialization of these novel plant-based drugs for indications such as attention-deficit/hyperactivity disorder (ADHD) and social anxiety disorder.
Filament Health Corp. Logo (CNW Group/Filament Health Corp.)
"We are thrilled with this collaboration with Filament Health, a company focused on discovering, developing and standardizing botanical drugs as well as the delivery to patients suffering from mental health conditions," said Steven King, PhD, Jaguar's Chief Sustainable Supply, Ethnobotanical Research & IP Officer and head of the company's Entheogen Therapeutics Initiative (ETI). Jaguar's ETI aims to discover and develop groundbreaking, novel, natural medicines derived from psychedelic and psychoactive plants for treatment of mood disorders, neurodegenerative diseases, addiction, and mental health disorders. "Jaguar and Filament are in the process of identifying plant candidates that may prove beneficial for addressing indications such as ADHD and social anxiety disorder, for which we plan to collaboratively work to develop botanical drugs."
"Filament is a leader in the development of botanical medicines, and we are dedicated to supporting the treatment of mental health conditions through our expertise and technology," said Benjamin Lightburn, Chief Executive Officer of Filament Health. "We have developed novel manufacturing and standardization techniques which we have applied to psilocybin, psilocin and ayahuasca. We are pleased to partner with Jaguar and look forward to working with their team to identify and standardize new entheogens."
Story continues
Under this partnership, Jaguar will have responsibility for the identification of plants that may offer novel mechanisms of action, as well as for botanical drug development and the raw material supply chain. Filament will be responsible for developing the manufacturing techniques required to produce standardized, pharmaceutical-grade drug candidates. The two companies will then jointly seek partnership with a potential licensee for full development and commercialization of novel drug candidates, with proceeds from the relationship split equally between Jaguar and Filament.
"We very much look forward to working with Filament on this initiative," said Lisa Conte, Jaguar's President, CEO and Founder. "Jaguar's core team began focusing more than 30 years ago on the development and commercialization of plant-based prescription medicines, and our Mytesi (crofelemer) product, approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy, is the only oral plant-based prescription medicine approved under FDA Botanical Guidance. Filament's expertise in natural product chemistry and drug development allows for the mobilization of a key asset we have generated over 30 years a library of 2,300 medicinal plants and 3,500 plant extracts, all from firsthand ethnobotanical investigation by Jaguar and our ETI Scientific Strategy Team (SST)."
The ETI SST will support this collaboration, and consists of leading and globally renowned ethnobotanists, physicians, and pharmacologists, as well as experts in the fields of natural product chemistry and neuropharmacology:
Michael J. Balick, Ph.D.: Considered one of the world's leading ethnobotanists and economic botanists; specialist in healing plants and toxic plants and their use by Indigenous peoples; research associate of the Brain Chemistry Labs of the Institute of EthnoMedicine; member of original scientific strategy team that contributed to development of Jaguar's plant library.
Thomas Carlson, M.D., M.S.: Ethnobotanist, botanist, physician; teaching professor of integrative biology at the University of California, Berkeley; member of original scientific strategy team that contributed to development of Jaguar's plant library; key architect of ethnomedical field research process conducted by ethnobotanist/physician teams of Jaguar predecessor company Shaman Pharmaceuticals.
Pravin Chaturvedi, Ph.D.: Pharmacologist with specialty in neuropharmacology; chair of the Scientific Advisory Board of Napo Pharmaceuticals (Napo), Jaguar's wholly-owned subsidiary, and the chief scientific officer of Jaguar; Over 25+ year career, led discovery and/or development activities for several new chemical entities including development of Napo's FDA-approved drug product, Mytesi (crofelemer), the only oral plant-based prescription medicine approved under FDA Botanical Guidance.
Julie Anne Chinnock, ND, MPH, ARNP/CRNA: Ethnobotanist; Doctor of Naturopathic Medicine; owner and manager of Ketamine clinic; part of original Shaman Pharmaceuticals field research teams; public health expert.
Stephen Dahmer, M.D.: Ethnomedical researcher and practicing integrative physician; expert on endocannabinoids who has conducted ethnomedical field research in tropical regions.
Wade Davis, Ph.D.: Ethnobotanist, anthropologist, writer, and professor of anthropology at University of British Columbia; extensive international ethnobotanical field research.
Elaine Elisabetsky, Ph.D.: Among world's leading ethnopharmacologists; professor in the pharmacology and biochemistry departments of the Universidade Federal do Rio Grande do Sul in Brazil; member of original scientific strategy team that contributed to development of Jaguar's plant library.
Nigel Gericke, M.B.B.Ch.: Medical doctor, ethnobotanist, and ethnopharmacologist; former advisory panelist to the United States Pharmacopoeia; longstanding member of the Medicinal Plants Specialist Group of the World Wide Fund For Nature; founding member of the Association for African Medicinal Plants Standards.
Maurice Iwu, Ph.D.: President of Bioresources Development Group and founder of International Center for Ethnomedicine and Drug Development (InterCEDD) in Nigeria; member of original scientific strategy team that contributed to development of Jaguar's plant library.
Steven R. King, Ph.D.: Ethnobotanist; Napo's chief sustainable supply and ethnobotanical research officer; managed Napo's original scientific strategy team and outcomes; research associate of the Brain Chemistry Labs of the Institute of EthnoMedicine.
Charles Limbach, M.D.: Ethnomedical specialist and family medicine physician; member of original scientific strategy team that contributed to development of Jaguar's plant library.
David Sesin, Ph.D.: Natural product chemist; Jaguar's chief manufacturing officer; created isolation and manufacturing process for Mytesi (crofelemer).
About Filament Health(OTCQB: FLHLF) (NEO: FH) (FSE: 7QS)
Filament Health is a clinical-stage natural psychedelic drug development company. Filament believes that safe, standardized, naturally-derived botanical medicines can improve the lives of many, with a mission to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural medicines, including psychedelic medicines, for clinical development. Filament is paving the way with the first-ever natural psychedelic drug candidates.
Learn more at http://www.filament.healthand on Twitter, Instagramand LinkedIn
About Jaguar Health, Jaguar Animal Health, Napo Pharmaceuticals, & Napo Therapeutics
Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Jaguar Animal Health is a tradename of Jaguar Health. Jaguar Health's wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human pharmaceuticals from plants harvested responsibly from rainforest areas. Our crofelemer drug product candidate is the subject of the OnTarget study, an ongoing pivotal Phase 3 clinical trial for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy. Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A. (f/k/a Napo EU S.p.A.), an Italian corporation established by Jaguar Health in Milan, Italy in 2021 that focuses on expanding crofelemer access in Europe.
For more information about Jaguar Health, please visit https://jaguar.health. For more information about Napo Pharmaceuticals, visit http://www.napopharma.com.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements." These include statements regarding the expectation that the collaboration between Jaguar and Filament will identify plant candidates that may prove beneficial for addressing indications such as ADHD and social anxiety disorder, and the expectation that this collaboration will identify and standardize new entheogens. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
SOURCE Filament Health Corp.
Cision
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/09/c5814.html
See the original post:
- Vermont Senate Passes Psychedelic Working Group Bill To Study How Entheogens Might Benefit Physical And Mental ... - Marijuana Moment - March 31st, 2024 [March 31st, 2024]
- Melissa Etheridge's New Book and Play Delve Into Her Son's Opioid ... - CelebStoner - October 29th, 2023 [October 29th, 2023]
- Walking the poison path: An interview with Coby Michael - The Wild Hunt - October 29th, 2023 [October 29th, 2023]
- Entheogenic drugs and the archaeological record - Wikipedia - April 14th, 2023 [April 14th, 2023]
- Learn All About The Top 10 Entheogens - Zamnesia Blog - February 20th, 2023 [February 20th, 2023]
- Entheogens and Psychedelics (including Ayahuasca, LSD, Peyote ... - December 12th, 2022 [December 12th, 2022]
- Terence McKenna - Wikipedia - October 23rd, 2022 [October 23rd, 2022]
- Enlightenment (spiritual) - Wikipedia - October 21st, 2022 [October 21st, 2022]
- Shamanism - Wikipedia - October 17th, 2022 [October 17th, 2022]
- The History Of: Hallucinogens, Psychedelics & Entheogens - August 25th, 2022 [August 25th, 2022]
- How Does Sound Therapy Enhance the Psychedelic Experience? - Psychedelic Spotlight - July 31st, 2022 [July 31st, 2022]
- Could we please have some consistency in our drug laws - Mail and Guardian - July 3rd, 2022 [July 3rd, 2022]
- 5 Next-Generation Psychedelics Entering Clinical Trials This Year - Psychedelic Spotlight - May 28th, 2022 [May 28th, 2022]
- Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder - Forbes - April 29th, 2022 [April 29th, 2022]
- Breaking down the decrim movement: Discoveries, doubts and personal ins & outs - Aspen Daily News - April 29th, 2022 [April 29th, 2022]
- Aztec use of entheogens - Wikipedia - March 29th, 2022 [March 29th, 2022]
- The Michigan Decriminalization of Psilocybin Mushrooms and Other Plants and Fungi Initiative Has Been Approved For Circulation As A Ballot Initiative... - February 24th, 2022 [February 24th, 2022]
- 5 Black Pioneers Combatting the Whitewashing of Psychedelics - Psychedelic Spotlight - February 17th, 2022 [February 17th, 2022]
- From Mycophobia to Mycophilia - The McGill Daily - The McGill Daily - February 17th, 2022 [February 17th, 2022]
- Entheogens and Plant Medicine: An Introduction Microdose - Microdose Psychedelic Insights - February 9th, 2022 [February 9th, 2022]
- Schumer Gives Update On Federal Marijuana Legalization And Banking In Meeting With Equity Advocates - Marijuana Moment - February 1st, 2022 [February 1st, 2022]
- USDA Teams Up With Cornell University For Hemp Education Webinar Series - Marijuana Moment - February 1st, 2022 [February 1st, 2022]
- Ohio Lawmakers Will Be Forced To Consider Marijuana Legalization As State Validates Activist Signatures - Marijuana Moment - February 1st, 2022 [February 1st, 2022]
- Psilocybin: Following in the Footsteps of Cannabis Along the Path to Legality - JD Supra - January 29th, 2022 [January 29th, 2022]
- What ketamine therapy taught me about my Jewish intergenerational trauma - Forward - January 29th, 2022 [January 29th, 2022]
- Debunking Myths and Misconceptions of the Psychedelics Industry - Rolling Stone - January 9th, 2022 [January 9th, 2022]
- What are you most excited for in Washtenaw County in 2022? - Concentrate - December 15th, 2021 [December 15th, 2021]
- Looking Into The Florida Bill That Proposes Decriminalization Of Psychedelics (And Every Other Illegal Dr - Benzinga - December 15th, 2021 [December 15th, 2021]
- The Wisdom of Agnosticism - The Humanist - December 15th, 2021 [December 15th, 2021]
- What Are Psychedelic Drugs (Hallucinogenics)? | Leafly - November 28th, 2021 [November 28th, 2021]
- Cannabis & Marijuana Education: Learn All About Weed | Leafly - November 28th, 2021 [November 28th, 2021]
- Vex - Destinypedia, the Destiny wiki - November 11th, 2021 [November 11th, 2021]
- Seattle City Council wants to decriminalize 'magic ... - November 11th, 2021 [November 11th, 2021]
- Tonight at 11: The unseen side of magic mushrooms, from moms to home growers - KIRO Seattle - November 11th, 2021 [November 11th, 2021]
- Guide to Entheogens: Plants, Therapy, Medicine - October 30th, 2021 [October 30th, 2021]
- What are entheogens and which are the best ones - October 30th, 2021 [October 30th, 2021]
- An upcoming election, pay requirement, and holiday, this week - KUOW News and Information - October 30th, 2021 [October 30th, 2021]
- Congressman Says He'll Bring The Psychedelics Reform Movement To Capitol Hill 'This Year' - Marijuana Moment - October 7th, 2021 [October 7th, 2021]
- From Cannabis MSO To Drug Development: Goodness Growth Wants To Understand Traditional Psychedelics Use - - Benzinga - September 16th, 2021 [September 16th, 2021]
- Jarvis Brookfield on his psychedelic paintings, dream-like states and what it means to be human - Creative Boom - September 12th, 2021 [September 12th, 2021]
- Oregon Psilocybin Panel Teams Up With Harvard To Research Psychedelic History And Impacts Of Reform - Marijuana Moment - September 12th, 2021 [September 12th, 2021]
- National Hemp Association Asks Congress To Budget $1 Billion To Support Industry Innovation - Marijuana Moment - September 12th, 2021 [September 12th, 2021]
- Psychedelic Drug Therapy: Tips and Support for the Experience - Greatist - August 28th, 2021 [August 28th, 2021]
- University of Michigan police say safety will be top priority at psychedelic shroom festival - MLive.com - August 22nd, 2021 [August 22nd, 2021]
- Two Years After Oakland's Psychedelic Decrim, What's Been the Impact? - Filter - August 4th, 2021 [August 4th, 2021]
- Psychedelics Decriminalization Advancing In Three More Cities, Spanning From Coast To Coast - Marijuana Moment - August 4th, 2021 [August 4th, 2021]
- Witch City Tarot & Divination Gathering | Coby Michael Ward - Patheos - July 29th, 2021 [July 29th, 2021]
- With Push From New Nonprofit, Arcata City Council Will Soon Consider a Resolution That Would Decriminalize Psychedelic Plants and Fungi in Arcata -... - July 7th, 2021 [July 7th, 2021]
- Group Hopes to Decriminalize Entheogens (Psychoactive Plant Substances) Within Arcata City Limits Redheaded Blackbelt - Redheaded Blackbelt - July 5th, 2021 [July 5th, 2021]
- Winners of Columbia@Roundabout's 2021 New Play Reading Series Announced - Broadway World - June 24th, 2021 [June 24th, 2021]
- Biden said he'd cut down on unemployment benefits, but he really might reinstate a pre-pandemic job-seeking policy The Madison Leader Gazette - The... - May 11th, 2021 [May 11th, 2021]
- The psychedelic revolution is coming. Psychiatry may never be the same - bdnews24.com - May 11th, 2021 [May 11th, 2021]
- Native Tribes Should Have More Say in the Psychedelic Movement - Green Entrepreneur - April 29th, 2021 [April 29th, 2021]
- Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief Effort in St. Vincent and the Grenadines - InvestorIntel - April 29th, 2021 [April 29th, 2021]
- Jews, Christians, and Muslims Are Reclaiming Ancient Psychedelic Practices, And That Could Help With Legalization - Rolling Stone - April 25th, 2021 [April 25th, 2021]
- Psychedelic Experience launches new website to help navigate the world of psychedelics - PRNewswire - April 25th, 2021 [April 25th, 2021]
- Zide Door Oaklands Church of Entheogenic Plants - April 15th, 2021 [April 15th, 2021]
- Opinion | Is it time for Seattle to decriminalize shrooms and psychedelics? - Crosscut - April 15th, 2021 [April 15th, 2021]
- Following Local Successes, Cambridge State Rep. Puts Forward Bills on Controlled Substance Reform | News - Harvard Crimson - March 29th, 2021 [March 29th, 2021]
- The Potential (and Peril) of Legalizing Psychedelics - Progressive.org - January 1st, 2021 [January 1st, 2021]
- Oakland continues move to protect entheogen plants - The Leaf Online - September 18th, 2020 [September 18th, 2020]
- The Only Obstacle To A Healthy World Is Government Secrecy And Propaganda - Scoop.co.nz - July 21st, 2020 [July 21st, 2020]
- There's More to the CHOP Than What the Media Will Have You Believe - Study Breaks - July 21st, 2020 [July 21st, 2020]
- Entheogens | Sacred Geometry - June 15th, 2020 [June 15th, 2020]
- Entheogen - Wikipedia - May 4th, 2020 [May 4th, 2020]
- The Return Trip: Psychedelics may come back from the abyss of illegality - Valley Advocate - November 23rd, 2019 [November 23rd, 2019]
- How San Francisco's Summer of Love sparked religious movements - The Oakland Press - August 25th, 2017 [August 25th, 2017]
- Outside the Box - HuffPost - August 13th, 2017 [August 13th, 2017]
- 'Summer of Love' shaped American lives, spiritual expression - Houston Chronicle - July 29th, 2017 [July 29th, 2017]
- The Summer of Love was more than hippies and LSD it was the start of modern individualism - The Independent - July 24th, 2017 [July 24th, 2017]
- How San Francisco's Summer of Love sparked today's religious movements - Religion News Service - July 22nd, 2017 [July 22nd, 2017]
- The Poisoner: Pharmakos and Veneficus-Poisoner's Apothecary - Patheos (blog) - July 19th, 2017 [July 19th, 2017]
- The Summer of Love was more than hippies and LSD it was the start of modern individualism - Metro Newspaper UK - July 8th, 2017 [July 8th, 2017]
- The Summer of Love was more than hippies and LSD it was the ... - The Conversation UK - July 7th, 2017 [July 7th, 2017]
- Entheogen - PsychonautWiki - July 1st, 2017 [July 1st, 2017]
- The History and Possibilities of Putting Weed in Your Witchcraft - Seattle Weekly - June 29th, 2017 [June 29th, 2017]
- Entheogens : Al-Kemi : spagyrics and alchemy - June 27th, 2017 [June 27th, 2017]
- Virtual Reality Takes Consciousness Research into Mystic Realms of the Divine Play - The Sociable - June 26th, 2017 [June 26th, 2017]
- Entheogen - June 15th, 2017 [June 15th, 2017]
- Entheogens | Drug War Facts - June 5th, 2017 [June 5th, 2017]